Evidence map›Paper›PMID 33996103›Full record

ArticleNew microbes and new infections2021

First detection of mobilized colistin resistance

F Nikkhahi, S Robatjazi, M Niazadeh, A Javadi, G H Shahbazi, P Aris, S M Amin Marashi, N Emam

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A review of colistin-resistantArchives of Razi Institute · 2024
    Review
  5. The battle against colistin-resistantNew microbes and new infections · 2023
    Article
  6. Article
  7. The prevalence of varicella zoster virus, herpes simplex virus type 2, and human papillomavirus in breast cancerous tissues and their adjacent ones in Iran.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Article
  8. Article
  9. Evaluation of mechanisms of colistin resistance inIranian journal of microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

F NikkhahiMedical Microbiology Research Center, Iran.
S RobatjaziMedical Microbiology Research Center, Iran.
M NiazadehMedical Microbiology Research Center, Iran.
A JavadiDepartment of Biostatics, Qazvin University of Medical Sciences, Qazvin, Iran.
G H ShahbaziMedical Microbiology Research Center, Iran.
P ArisMedical Microbiology Research Center, Iran.
S M Amin MarashiMedical Microbiology Research Center, Iran.
N EmamDepartment of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRQazvin University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, few studies have investigated the mechanisms of resistance to colistin in Iran. The aim of this study was to investigate

Indexed as

Colistin resistanceEscherichia colilivestockmcr-1

Identifiers

PMID33996103
PMCPMC8086131
OpenAlexW3137137909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.